Free Trial

Context Therapeutics (CNTX) SEC Filings & 10K Form

Context Therapeutics logo
$2.27
+0.09 (+4.13%)
(As of 11/1/2024 ET)

Recent Context Therapeutics SEC Filings

DateFilerForm TypeView
09/23/2024
6:33 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
3:22 PM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:15 AM
Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:01 AM
Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2024
7:04 AM
Context Therapeutics (Issuer)
Walker Luke Nathaniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:08 AM
Context Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2024
6:34 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
4:15 PM
Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
4:18 PM
Context Therapeutics (Issuer)
Dansky Ullmann Claudio (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:07 PM
Context Therapeutics (Filer)
Form DEFA14A
07/24/2024
3:55 PM
Context Therapeutics (Filer)
Form DEF 14A
07/10/2024
6:33 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
6:52 AM
Context Therapeutics (Issuer)
Stacey Jennifer Evans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:41 AM
BERMAN RICHARD J (Reporting)
Context Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:47 AM
Context Therapeutics (Issuer)
West Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:50 AM
Context Therapeutics (Issuer)
Kantoff Philip W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:34 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
9:45 AM
Context Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
06/02/2024
11:15 PM
Context Therapeutics (Filer)
Form EFFECT
05/24/2024
6:31 AM
Context Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/13/2024
9:37 AM
Avidity Partners Management LP (Filed by)
Context Therapeutics (Subject)
Form SC 13G
05/02/2024
6:37 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:16 PM
Context Therapeutics (Filer)
Form ARS
04/26/2024
3:12 PM
Context Therapeutics (Filer)
Form DEFA14A
04/01/2024
6:32 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
7:01 AM
Context Therapeutics (Issuer)
Lehr Martin A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:01 AM
Context Therapeutics (Issuer)
Levit Alex C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:04 AM
Context Therapeutics (Issuer)
Minai-Azary Jennifer Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:28 AM
Context Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:36 AM
Context Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
6:31 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
6:30 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
3:24 PM
Context Therapeutics (Subject)
Lehr Martin A. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners